Abstract
Keywords
Get full access to this article
View all access options for this article.
References
1.
Aggeler
P. M.
: Potentiation of Anticoagulant Effect of Warfarin by Phenylbutazone , New Engl. J. Med.
276 : 496 (Mar. 2) 1967 . (OCH).
2.
Anon
: Effects of Drugs on the PBI and Ta Uptake , Med. Letter
9 : 82 (Oct. 20) 1967 . (R).
3.
Anton
A. H.
: A Drug-Induced Change in the Distribution and Renal Excretion of Sulfonamides , J. Pharmacol. Exptl. Therap.
129 : 282 , 1960 . (OA).
4.
Bluestone
R.
: Effects of Drugs on Urate Binding to Plasma Proteins , Brit. Med. J.
4 : 590 (Dec. 6) 1969 . (OH).
5.
Burns
J. J.
: Application of Drug Metabolism to Drug Toxicity Studies , Ann. N.Y. Acad. Sci.
123 : 273 (Mar.) 1965 . (R).
6.
Chen
W.
: Accelerated Aminopyrine Metabolism in Human Subjects Pretreated with Phenylbutazone , Life Sci.
2 : 35 , 1962 .
7.
Christensen
L. K.
Skovsted
L.
: Inhibition of Drug Metabolism by Chloramphenicol , Lancet
2 : 1397 (Dec. 27) 1969 . (OH).
8.
Christensen
L. K.
: Sulphaphenazole-Induced Hypoglycaemic Attacks in Tolbutamide-Treated Diabetics , Lancet
2 : 1298 (Dec. 21) 1963 . (OCHT).
9.
Conney
A. H.
Schneidman
K.
: Enhanced Androgen Hydroxylase Activity in Liver Microsomes of Rats and Dogs Treated with Phenylbutazone , J. Pharmacol. Exptl. Therap.
146 : 225 (Nov.) 1964 .
10.
Conney
A. H.
: Drug-Induced Changes in Steroid Metabolism , Ann. N.Y. Acad. Sci.
123 : 98 (Mar.) 1965 . (R).
11.
Conney
A. H.
: Effects of Pesticides on Drug and Steroid Metabolism , Clin. Pharmacol. Therap.
8 : 2 (Jan.-Feb.) 1968 . (OA).
12.
Eddy
J. D.
Mackinnon
J.
: Anticoagulants-Butazolidin , Brit. Med. J.
3 : 435 (Aug. 12) 1967 . (CH).
13.
Eisen
M. J.
: Combined Effects of Sodium Warfarin and Phenylbutazone , J. Am. Med. Assoc.
189 : 64 (July 6) 1964 . (CH).
14.
Field
J. B.
: Potentiation of Acetohexamide Hypoglycemia by Phenylbutazone , New Engl. J. Med.
277 : 889 (Oct. 26) 1967 . (OH).
15.
Fox
S. L.
: Potentiation of Anticoagulants Caused by Pyrazole Compounds , J. Am. Med. Assoc.
188 : 320 (Apr. 20) 1964 . (CH).
16.
Goodman
L. S.
Gilman
A.
: The Pharmacological Basis of Therapeutics , 4th ed. , Macmillan , N.Y.
1970
334a , 336b .
17.
Hansen
J. M.
: Dicumarol-Induced Diphenylhydantoin Intoxication , Lancet
2 : 265 (July 30) 1966 . (OH).
18.
Hoffbrand
B. I.
Kininmonth
D. A.
: Potentiation of Anticoagulants , Brit. Med. J.
2 : 838 (June 24) 1967 . (CH).
19.
Kampfmeyer
H. G.
: Failure to Detect Increased Elimination Rate of Phenacetin in Man After Treatment with Phenobarbital , Klin. Wochschr.
47 : 1237 (Oct.) 1969 .
20.
Kuntzman
R.
: Effect of Phenylbutazone on Cortisol Metabolism in Man , Pharmacologist
8 : 195 , 1966 .
21.
Levi
A. J.
: Phenylbutazone and Isoniazid Metabolism in Patients with Liver Disease in Relation to Previous Drug Therapy , Lancet
1 : 1225 (June 15) 1968 . (OH).
22.
Lucas
B. G.
: “Dilantin” Overdosage (Correspondence) , Med. J. Australia
2 : 639 (Oct. 12) 1967 .
23.
Lunde
P. K. M.
: Plasma Protein Binding of Diphenylhydantoin in Man , Clin. Pharmacol. Therap.
11 : 846 (Nov.–Dec.) 1970 . (OTH).
24.
Maickel
R. P.
: Pharmacologist
1 : 182 , 1965 .
25.
Mayer
G. A.
: A Rare Complication of Coumadin-Congener Anticoagulant Therapy (Correspondence) , Can. Med. Assoc. J.
93 : 1042 (Nov. 6) 1965 .
26.
McLaughlin
G. E.
: Hemarthrosis and Anticoagulants (Letters) , Ann. Internal Med.
71 : 867 (Oct.) 1969 .
27.
McLaughlin
G. E.
McCarthy
O. J.
: Hemarthrosis Complicating Anticoagulant Therapy , J. Am. Med. Assoc.
196 : 1020 (June 13) 1966 . (CH).
28.
Mielens
Z. E.
: Interaction of Aspirin with Nonsteroidal Anti-Inflammatory Drugs in Rats (Letters) , J. Pharm. Pharmacol.
20 : 567 (July) 1968 . (OA).
29.
O'Reilly
R. A.
Levy
G.
: Pharmacokinetic Analysis of Potentiating Effect of Phenylbutazone on Anticoagulant Action of Warfarin in Man , J. Pharm. Sci.
59 : 1258 (Sept.) 1970 . (O).
30.
Oyer
J. H.
: Suppression of Salicylate-Induced Uricosuria by Phenylbutazone , Am. J. Med. Sci.
251 : 1 (Jan.) 1966 . (OH).
31.
Poland
A.
: Effect of Intensive Occupational Exposure to DDT on Phenylbutazone and Cortisol Metabolism in Human Subjects , Clin. Pharmacol. Therap.
11 : 724 (Sept.-Oct.) 1970 . (OH).
32.
Solomon
H. M.
Schrogie
J. J.
: The Anticoagulant Response to Bishydroxycoumarin, I. The Role of Individual Variation , Clin. Pharmacol. Therap.
8 : 65 (Jan.-Feb.) 1967 . (OH).
33.
Taylor
P. J.
: Hemorrhage While on Anticoagulant Therapy by Drug Interaction , Arizona Med.
24 : 697 (Aug.) 1967 . (CH).
34.
Udall
J. A.
: Drug Interference with Warfarin Therapy , Am. J. Cardiol.
23 : 143 (Jan.) 1969 . (OH).
35.
Vesell
E. S.
: Genetic Control of Phenobarbital Induced Shortening of Plasma Antipyrine Half-Lives in Man , J. Clin. Invest.
48 : 2202 (Dec.) 1965 . (OH).
36.
Weiner
M.
: Drug Interactions: The Effect of Combined Administration on the Half-Life of Coumarin and Pyrazolone Drugs in Man , Fed. Proc.
24 : 153 , 1965 .
37.
Welch
R. M.
: An Experimental Model in Dogs for Studying Interactions of Drugs with Bishydroxycoumarin , Clin. Pharmacol. Therap.
10 : 817 (Nov.–Dec.) 1969 . (OA).
38.
Whittaker
J. A.
: Genetic Control of Phenylbutazone Metabolism in Man , Brit. Med. J.
4 : 323 (Nov. 7) 1970 . Additional References Not Reviewed by This Author.
39.
Kindermann
A.
: Vaskulares Allergid nack Butazolidin und Gefahren kombinieter Anwendung mit Athrombon (Phenylindandion) , Dermatol. Wochschr.
143 : 172 , 1961 .
40.
Mathies
H.
: Experimental Studies in Humans on the Synergistic Action of Prednisolone and Phenylbutazone, (Ger.) .
41.
Sigg
A.
: Verstarkung der Antikoagulantienwirkung durch Butazolidin , Schweiz. Med. Wochschr.
86 : 1194 , 1956 .
42.
Riesterer
L.
Jacques
R.
: Interference by β-Adrenergic Blocking Agents with the Anti-Inflammatory Action of Various Drugs , Helv. Physiol. Acta
26 : 287 , 1968 .
43.
King
T. M.
Burgard
J. K.
: Drug Interactions , Am. J. Obstet. Gynecol.
98 : 128 (May 1) 1967 . (R).